Linezolid
Participants assigned to linezolid receive 600 mg orally twice daily for 5 days. No linezolid dose modifications are allowed, including for renal impairment. Linezolid is being tested because preclinical studies indicate it suppresses S. a…
1 sources - 4 claims
Participants assigned to linezolid receive 600 mg orally twice daily for 5 days. No linezolid dose modifications are allowed, including for renal impairment. Linezolid is being tested because preclinical studies indicate it suppresses S. aureus virulence factors linked to persistence and tissue damage. The LIPS trial tests whether early adjunctive linezolid can improve outcomes beyond bacterial clearance alone.